Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells

BMB Reports

Volumn 48, Issue 8, 2015, Pages 461-466

  Eom, Dae Woon ^a   Lee, Ji Hwan ^b   Kim, Young Joo ^b   Hwang, Gwi Seo ^c   Kim, Su Nam ^b   Kwak, Jin Ho ^a   Cheon, Gab Jin ^a   Kim, Ki Hyun ^d   Jang, Hyuk Jai ^a   Ham, Jungyeob ^b   Kang, Ki Sung ^c   Yamabe, Noriko ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

Curcumin; Epigallocatechin gallate; Growth arrest; p21; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; CURCUMIN; EPIGALLOCATECHIN GALLATE;

ANALOGS AND DERIVATIVES; CELL CYCLE CHECKPOINT; CELL DIVISION; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; HUMAN; MALE; PROSTATIC NEOPLASMS; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATECHIN; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; MALE; PROSTATIC NEOPLASMS; UP-REGULATION;

EID: 84944754102     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.8.216     Document Type: Article

References (35)

1. Siegel R, Ward E, Brawley O and Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61, 212-236
2. Lange PH and Vessella RL (1998) Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone. Cancer Metastasis Rev 17, 331-336
3. Bubendorf L, Schopfer A, Wagner U et al (2000) Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients. Hum Pathol 31, 578-583
4. Roudier MP, Morrissey C, True LD, Higano CS, Vessella RL and Ott SM (2008) Histopathological assessment of prostate cancer bone osteoblastic metastases. J Urol 180, 1154-1160
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893-2917
6. Vickers A (2002) Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 20, 1069-1079
7. Shimizu M, Adachi S, Masuda M, Kozawa O and Moriwaki H (2011) Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Mol Nutr Food Res 55, 832-843
8. Yang H, Landis-Piwowar K, Chan TH and Dou QP (2011) Green tea polyphenols as proteasome inhibitors: Implication in chemoprevention. Cancer Drug Targets 11, 296-306
9. Sintara K, Thong-Ngam D, Patumraj S and Klaikeaw N (2012) Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats. J Biomed Biotechnol 2012, 1-8
10. Yang CS, Wang X, Lu G and Picinich SC (2009) Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9, 429-439
11. Kim JW, Amin AR and Shin DM (2010) Chemoprevention of head and neck cancer with green tea polyphenols. Cancer Prev Res 3, 900-909
12. Ahmad N, Gupta S and Mukhtar H (2000) Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys 376, 338-346
13. Adhami VM, Ahmad N and Mukhtar H (2003) Molecular targets for green tea in prostate cancer prevention. J Nutr 133, 2417-2424
14. Borska S, Gebarowska E, Wysocka T, Drag-Zalesinska M and Zabel M (2003) Induction of apoptosis by EGCG in selected tumour cell lines in vitro. Folia Histochem Cytobiol 41, 229-232
15. Ahmad KA, Harris NH, Johnson AD, Lindvall HC, Wang G and Ahmed K (2007) Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells. Mol Cancer Ther 6, 1006-1012
16. Chung LY, Cheung TC, Kong SK et al (2001) Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci 68, 1207-1214
17. Hastak K, Agarwal MK, Mukhtar H and Agarwal ML (2005) Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J 19, 789-791
18. Kuttan G, Kumar KB, Guruvayoorappan C and Kuttan R (2007) Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv Exp Med Biol 595, 173-184
19. Kunnumakkara AB, Anand P and Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269, 199-225
20. Zhang X, Chen LX, Ouyang L, Cheng Y and Liu B (2012) Plant natural compounds: Targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Prolif 45, 466-476
21. Shehzad A, Wahid F and Lee YS (2010) Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm 343, 489-499
22. Mukhtar H and Ahmad N (1999) Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol 158, 207-210
23. McCarty MF (2004) Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy. Integr Cancer Ther 3, 349-380
24. Banerjee S, Zhang Y, Ali S et al (2005) Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res 65, 9064-9072
25. Khor TO, Keum YS, Lin W et al (2006) Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 66, 613-621
26. Narayanan BA, Narayanan NK, Pttman B and Reddy BS (2006) Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition. Prostate 66, 257-265
27. Adhami VM, Malik A, Zaman N et al (2007) Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 13, 1611-1619
28. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58, 621-681
29. Suganuma M, Saha A and Fujiki H (2011) New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102, 317-323
30. Stone A, Sutherland RL and Musgrove EA (2012) Inhibitors of cell cycle kinases: Recent advances and future prospects as cancer therapeutics. Crit Rev 17, 175-198
31. Chauhan DP (2002) Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm 8, 1695-1706
32. Shankar S, Suthakar G and Srivastava RK (2007) Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci 12, 5039-5051
33. Saha A, Kuzuhara T, Echigo N, Suganuma M and Fujiki H (2010) New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin. Cancer Prev Res 3, 953-962
34. Kim S, Lee MJ, Hong J et al (2000) Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer 37, 41-48
35. Somers-Edgar TJ, Scandlyn MJ, Stuart EC, le Nedelec MJ, Valentine SP and Rosengren RJ (2008) The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo. Int J Cancer 122, 1966-1971